Delivery Order SPE2DB20D3103-SPE2DB25FQ0M7
- Not listed
- The Defense Logistics Agency awarded a $5,608.29 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Telmisartan 20 mg tablets in quantities of 30 units, with an ultimate completion date of July 30, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Telmisartan 80 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract was executed on August 4, 2025, with a ceiling value of $3,660.86 and an ultimate completion date of August 5, 2025. The contract utilizes firm fixed pricing and represents a delivery order under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Telmisartan 20 mg tablets (30-count) on July 22, 2025, with a ceiling value of $3,018.90 and an ultimate completion date of July 23, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This award is a...
- The Defense Logistics Agency awarded a delivery order valued at $1,029.32 to AmerisourceBergen Drug Corp for the supply of Telmisartan 40 mg tablets (30-count) on August 21, 2025, with a completion date of August 22, 2025. This non-set-aside, competitively awarded contract employs firm fixed price terms and designates AmerisourceBergen's Conshohocken, Pennsylvania location as the place of performance. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $3,029.76 delivery order to AmerisourceBergen Drug Corp for Telmisartan 80 mg tablets (30-count) on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,137.56 to AmerisourceBergen Drug Corp for the supply of Telmisartan 40 mg tablets (30-count units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement and specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $1,093.50 to AmerisourceBergen Drug Corp for the supply of Telmisartan 40 mg tablets (30-count packaging) on August 14, 2025, with completion scheduled for August 15, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Telmisartan 20 mg tablets in quantities of 30 units. This contract, valued at $6,670.08, represents a firm fixed price delivery order with an ultimate completion date of August 21, 2025. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Telmisartan 40 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $3,555.12. This non-set-aside competitive award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999.99 billion and extending through December 2026. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $2,314.14 to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30-count packages). The contract, executed on August 18, 2025, with an ultimate completion date of August 19, 2025, is structured as a firm fixed price delivery order with no set-aside designation. This award represents a competitive procurement under AmerisourceBergen's existing Indefinite Delivery Contract (IDC)...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ0M7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $11,985.43 to AmerisourceBergen Drug Corp for the supply of Telmisartan 20 mg tablets (30-count units) on August 27, 2025, with completion scheduled for August 28, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive pharmaceutical supply vehicle valued at $1 billion through December 2026 that enables the company to distribute a broad range of pharmaceuticals and medical supplies to support military healthcare systems globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting Defense Health Agency operations and military healthcare programs. The company's extensive portfolio of federal contract awards demonstrates its capability to fulfill open competition requirements across multiple therapeutic domains, including antihypertensive medications such as Telmisartan. The DLA Troop Support Medical contract vehicle provides AmerisourceBergen with the flexibility to respond to federal healthcare requirements across diverse geographic regions and customer bases, positioning it as a key supplier within the military's pharmaceutical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.0k | 8/27/25 |